SpiderRock Advisors LLC Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

SpiderRock Advisors LLC grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 2,325 shares of the biotechnology company’s stock after acquiring an additional 58 shares during the period. SpiderRock Advisors LLC’s holdings in Axon Enterprise were worth $929,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in AXON. Quent Capital LLC lifted its position in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares during the period. Blue Trust Inc. lifted its holdings in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Friedenthal Financial bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $51,000. Reston Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $60,000. Finally, Asset Dedication LLC bought a new position in Axon Enterprise during the 2nd quarter valued at approximately $47,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on AXON. Craig Hallum boosted their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Northland Securities increased their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Robert W. Baird lifted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Bank of America initiated coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price on the stock. Finally, Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $412.42.

Axon Enterprise Stock Performance

AXON stock opened at $603.18 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 1 year low of $212.88 and a 1 year high of $611.88. The company has a market cap of $45.58 billion, a P/E ratio of 155.86, a price-to-earnings-growth ratio of 15.15 and a beta of 0.94. The stock’s fifty day moving average price is $414.16 and its 200-day moving average price is $347.59.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the sale, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 369,172 shares of company stock valued at $136,270,842. 6.10% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.